Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 10-1991 | 10-1990 | 10-1989 | 10-1988 | 10-1987 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 2,510 | 2,058 | 1,424 | 674 | 487 |
| TOTAL | $2,510 | $2,058 | $1,424 | $674 | $487 |
| Non-Current Assets | |||||
| PPE Net | 7,804 | 8,211 | 8,489 | 7,548 | 6,653 |
| Other Non-Current Assets | 4,796 | 4,901 | 4,786 | 5,127 | 6,265 |
| TOTAL | $12,600 | $13,112 | $13,275 | $12,675 | $12,918 |
| Total Assets | $15,110 | $15,170 | $14,699 | $13,349 | $13,405 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 0 | 0 | 102 |
| Accounts payable and accrued liabilities | 3,527 | 3,411 | 4,782 | 3,956 | 3,149 |
| Accrued Expenses | 2,653 | 2,743 | 2,177 | 1,833 | 1,462 |
| TOTAL | $7,398 | $7,555 | $8,346 | $8,003 | $5,857 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 751 | 690 | 363 | 623 | 609 |
| TOTAL | $2,562 | $2,595 | $1,596 | $1,425 | $1,045 |
| Total Liabilities | $9,960 | $10,150 | $9,942 | $9,428 | $6,902 |
| Shareholders' Equity | |||||
| Common Shares | 54 | 54 | 43 | 43 | 30 |
| Other shareholders' equity | 447 | -287 | -106 | -45 | -377 |
| TOTAL | $20,125 | $22,391 | $25,369 | $24,858 | $10,282 |
| Total Liabilities And Equity | $30,085 | $32,541 | $35,311 | $34,286 | $17,184 |